tirzepatide study for Heart Failure with Preserved Ejection Fraction and Obesity What Are the Pharmacodynamics of

The results of the primary analysis for both change from baseline in HbA1c and body weight were supported by the results of the sensitivity analyses, which accounted for different sets of populations, estimands and analytical approaches to minimize bias

Garvey WT

Martin KankamOne of the clinical investigators who participated in the conduct of the study, which was sponsored by Novo Nordisk

Common scenarios include achieving target weight loss goals, experiencing intolerable adverse effects such as persistent nausea or gastrointestinal disturbances, financial constraints related to medication costs, pregnancy planning or confirmation (tirzepatide should be discontinued when pregnancy is recognized), or development of contraindications

Metformin addresses hepatic glucose production while tirzepatide handles incretin-mediated insulin sensitization, appetite regulation, and weight management

Schedule a consultation with a PEAK clinician